ABIONYX Pharma SA (EPA:ABNX)
France · Delayed Price · Currency is EUR 4.150
-0.035 (-0.84%)
Nov 24, 2025, 5:35 PM CET
ABIONYX Pharma Market Cap
ABIONYX Pharma has a market cap or net worth of €145.12 million as of November 24, 2025. Its market cap has increased by 207.72% in one year.
Market Cap
145.12M
Enterprise Value
145.87M
Revenue
4.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
€4.15
Market Cap Chart
Since March 30, 2015, ABIONYX Pharma's market cap has decreased from 214.16M to 145.12M, a decrease of -32.24%. That is a compound annual growth rate of -3.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 145.12M | 251.68% |
| Dec 31, 2024 | 41.27M | -0.54% |
| Dec 29, 2023 | 41.49M | -14.37% |
| Dec 30, 2022 | 48.45M | -28.38% |
| Dec 31, 2021 | 67.65M | 178.53% |
| Dec 31, 2020 | 24.29M | 229.66% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 141.11B |
| Sanofi | 105.04B |
| Sartorius Stedim Biotech | 18.49B |
| bioMérieux | 12.72B |
| Ipsen | 10.44B |
| Eurofins Scientific SE | 10.24B |
| ABIVAX Société Anonyme | 7.75B |
| Virbac | 2.99B |